Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Dimerizing drug that binds to mutated Fas protein/drug-binding domain fusion protein (FKBP)
Date Designated: 11/24/1999
Orphan Designation: Treatment of acute graft-versus-host disease in patients undergoing bone marrow transplantation.
Orphan Designation Status: Designated/Designation Withdrawn or Revoked
Date Designation Withdrawn or Revoked: 10/24/2023
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Bellicum Pharmaceuticals, Inc.
6400 Fannin Street
Suite 2300
Houston, Texas 77030
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-